Absorption Systems Appoints Lorraine Hendry International Business Development Manager

Share Article

Absorption Systems, a leader in preclinical ADMET testing of drugs, adds Lorraine Hendry, a dynamic sales professional, to its sales team. She will cover Europe, the Middle East, and Australia.

Absorption Systems, a global leader in preclinical testing of drugs for ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) and medical devices for efficacy and safety, today announced that the company has hired Lorraine Hendry as International Business Development Manager. In this role, Ms. Hendry will be responsible for sales and account management in Europe, the UK, the Middle East, and Australia. She is based in Scotland, between Glasgow and Edinburgh.

“Lorraine’s varied experience in technical and scientific sales will serve her well in this new role. We are very excited to have her as part of our team,” said Patrick M. Dentinger, President and Chief Executive Officer of Absorption Systems. “She has a proven track record of growing sales in several fields within this territory and will not be shy about growing ours.”

Ms. Hendry comes to Absorption Systems from Touch Bionics, a developer of bionic prosthetic hands, where she was an international sales representative. Prior to that, she spent nearly six years in sales, sales management, and training for Ashfield In2Focus, a contract pharmaceutical sales and marketing firm. She earned her Bachelor of Science degree in Biochemistry from the University of Dundee, followed by several years of laboratory experience.

“Absorption Systems is highly regarded and clearly a leader in its field,” said Ms. Hendry. “I look forward to meeting our customers and bringing new ones on board. The changes in the pharmaceutical industry are creating tremendous outsourcing opportunities.”

About Absorption Systems
Absorption Systems, founded in 1996, assists pharmaceutical and medical device companies in identifying and overcoming ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) barriers in the development of drugs and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes when they occur. The CellPort Technologies® platform, a suite of human cell-based tests systems for drug transporter characterization, exemplifies Absorption Systems' commitment to innovation and is soon to be an industry assay standard for in vitro drug interaction assessment. Absorption Systems has facilities near Philadelphia, PA, and San Diego, CA, and serves customers throughout the world. For information on the company's comprehensive contract services and applied research programs, please visit http://www.absorption.com.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Bode
Absorption Systems
(1) 610-280-1451
Email >
Visit website

Media